<?xml version="1.0" encoding="UTF-8"?>
<ref id="B177-pharmaceutics-12-00688">
 <label>177.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ribeiro</surname>
    <given-names>I.A.</given-names>
   </name>
   <name>
    <surname>Faustino</surname>
    <given-names>C.M.</given-names>
   </name>
   <name>
    <surname>Guerreiro</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Frade</surname>
    <given-names>R.F.</given-names>
   </name>
   <name>
    <surname>Bronze</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Castro</surname>
    <given-names>M.F.</given-names>
   </name>
   <name>
    <surname>Ribeiro</surname>
    <given-names>M.H.</given-names>
   </name>
  </person-group>
  <article-title>Development of novel sophorolipids with improved cytotoxic activity toward MDA-MB-231 breast cancer cells</article-title>
  <source>J. Mol. Recognit.</source>
  <year>2015</year>
  <volume>28</volume>
  <fpage>155</fpage>
  <lpage>165</lpage>
  <pub-id pub-id-type="doi">10.1002/jmr.2403</pub-id>
  <?supplied-pmid 25647712?>
  <pub-id pub-id-type="pmid">25647712</pub-id>
 </element-citation>
</ref>
